I know a fair bit about COVID. I spent a fairly large part of my life reading research about COVID. And I'm a good reader—it's part of my job. I'm not doing any epidemiology on my own. The problem is that ACIP's recommendations on vaccine prioritization don't match the research.https://twitter.com/mikeandallie/status/1340474677081366528 …
-
-
Of course it’s not simple but we need to make decisive trade offs. What should we be prioritizing here?
-
Some potential considerations that Nate is ignoring: 1. Process issues 2. Biggest benefit in QALYs or equivalent 3. Equity 4. Rule of rescue 5. Non-death complications 6. Disease spreading Off the top of my head
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
